
Susan E. Funk, MBA, FACHE
Advertisement
Articles by Susan E. Funk, MBA, FACHE
Advertisement
Latest Updated Articles
Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System InhibitorsPublished: August 31st 2016 | Updated:
All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease StagePublished: June 21st 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
2
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
3
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
4
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
5



